D402-0170 Screening compound: 9-(2,5-dimethoxyphenyl)-8-(3,4-dimethoxyphenyl)-4,9-dihydro[1,2,3,4]tetraazolo[1',5':1,2]pyrimido[4,5-d]pyridazin-5-ol

D402-0170 Screening compound: 9-(2,5-dimethoxyphenyl)-8-(3,4-dimethoxyphenyl)-4,9-dihydro[1,2,3,4]tetraazolo[1',5':1,2]pyrimido[4,5-d]pyridazin-5-ol
D402-0170 Screening compound: 9-(2,5-dimethoxyphenyl)-8-(3,4-dimethoxyphenyl)-4,9-dihydro[1,2,3,4]tetraazolo[1',5':1,2]pyrimido[4,5-d]pyridazin-5-ol alternative view

Chemical Structure Depiction of ChemDiv screening compound D402-0170
9-(2,5-dimethoxyphenyl)-8-(3,4-dimethoxyphenyl)-4,9-dihydro[1,2,3,4]tetraazolo[1',5':1,2]pyrimido[4,5-d]pyridazin-5-ol

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D402-0170

Molecular Formula

C22H21N7O5 (C22 H21 N7 O5)

Compound Name

9-(2,5-dimethoxyphenyl)-8-(3,4-dimethoxyphenyl)-4,9-dihydro[1,2,3,4]tetraazolo[1',5':1,2]pyrimido[4,5-d]pyridazin-5-ol

IUPAC name

8-(25-dimethoxyphenyl)-10-(34-dimethoxyphenyl)-245671112-heptaazatricyclo[7.4.0.0^{37}]trideca-1(9)351012-pentaen-13-ol

SMILES

COc(cc1)cc(C2n3nnnc3Nc3c2c(-c(cc2)cc(OC)c2OC)nnc3O)c1OC

InChI

InChI=1S/C22H21N7O5/c1-31-12-6-8-14(32-2)13(10-12)20-17-18(11-5-7-15(33-3)16(9-11)34-4)24-25-21(30)19(17)23-22-26-27-28-29(20)22/h5-10,20H,1-4H3,(H,25,30)(H,23,26,28)/t20-/m0/s1

InChI Key

QVOIJJXRTSBACS-FQEVSTJZSA-N

MDL Number (MFCD)

MFCD09157307

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

463.45

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

12

Partition Coefficient, logP

1.869

Distribution Coefficient, logD

1.869

Water Solubility, LogSw

-2.31

Polar Surface Area

120.200

Acid Dissociation Constant (pKa)

7.06

Base Dissociation Constant (pKb)

10.80

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

22.70

D402-0170 in Drug Discovery

Included in Screening Libraries

Antifungal Library (16415 compounds)

Antimitotic Tubulin Library (17355 compounds)

Antiviral HBV Library (10007 compounds)

Protein-Protein Interaction Library (218420 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Immune system
  • animal
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Antiviral
  • Infections
  • Immune system
Agro:
  • Agro
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with D402-0170 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D402-0170?
Check Price and Availability of D402-0170, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D402-0170 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D402-0170
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D402-0170
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D402-0170 available by request